Lupin,
India’s fourth-largest drug-maker by sales is planning to launch
three-four new generic drugs in its key US market by end of FY13. So
far, the company has launched six products in this fiscal in the United
States, which generates about 42% of its total formulation sales.
Get Free MCX Tips, Stock Tips, Forex Tips & NCDEX Tips,Commodity Tips, Share Tips, commodity tips free trial, nifty free tips, commodity trading tips, shares tips, Share Market Tips, Stock Market Tips, free stock tips on mobile, Stock trading tips, Intraday Tips.
Get Free MCX Tips, Stock Tips, Forex Tips & NCDEX Tips,Commodity Tips, Share Tips, commodity tips free trial, nifty free tips, commodity trading tips, shares tips, Share Market Tips, Stock Market Tips, free stock tips on mobile, Stock trading tips, Intraday Tips.
No comments:
Post a Comment